Why take 10 years to launch a new biotech product when you can do it much faster?
Panel discussion summary
Accelerating Biotech Innovation Through Digital Transformation: This panel explores how digital technologies can revolutionize the traditional 10-year biotech development cycle. Experts from startups, Big Pharma, and research discuss compression of time-to-market while maintaining quality and safety. Key topics include digital transformation, biotechnology innovations, physical-digital convergence, and sustainable approaches. The session showcases integrated solutions from lab automation to analytics that optimize the R&D-to-production lifecycle.
Date, time and room information
May 6, 12:15-13:00, room MCH Lounge
Moderation
| Name | Position | Institution |
|---|---|---|
| Jens Feddern | Vertical Market Manager Life Science | Siemens Schweiz AG |
Panelists
| Name | Position | Institution |
|---|---|---|
| Lutz Salomon | Technical Account Manager for Pharma | Siemens Schweiz AG |
| Pascal Torregrossa | Givaudan | |
| Delphine Demeestere | Lonza | |
| Pierre Rocheteau | Olgram | |
| Ana Turk | Roche |
Siemens Schweiz AG
Digitalization and automation are of critical importance for the competitiveness of the pharmaceutical and life sciences industry. Through the use of state-of-the-art software and hardware, we support ideal work environments with high flexibility to shorten time-to-market and maintain quality. Discover how you can leverage Siemens' expertise and experience in research, production, and infrastructure to win the race against time.
Further information
Host and event manager:
Logistics and marketing partner:
